Impel Pharmaceuticals (IMPL) - 2021 Q2 - Quarterly Report
Impel Pharmaceuticals Impel Pharmaceuticals (US:IMPL)2021-08-16 12:04

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40353 IMPEL NEUROPHARMA, INC. (Exact name of Registrant as specified in its Charter) (State or other jurisdiction of incorporatio ...